WO2002012274A3 - Iapl-3 a protein inhibitor of apoptosis proteins - Google Patents

Iapl-3 a protein inhibitor of apoptosis proteins Download PDF

Info

Publication number
WO2002012274A3
WO2002012274A3 PCT/EP2001/008934 EP0108934W WO0212274A3 WO 2002012274 A3 WO2002012274 A3 WO 2002012274A3 EP 0108934 W EP0108934 W EP 0108934W WO 0212274 A3 WO0212274 A3 WO 0212274A3
Authority
WO
WIPO (PCT)
Prior art keywords
iapl
protein inhibitor
apoptosis proteins
polypeptides
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/008934
Other languages
French (fr)
Other versions
WO2002012274A2 (en
Inventor
Bernd Hentsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to JP2002518246A priority Critical patent/JP2004505639A/en
Priority to CA002418834A priority patent/CA2418834A1/en
Priority to EP01971851A priority patent/EP1307483A2/en
Priority to AU2001291722A priority patent/AU2001291722A1/en
Priority to US10/343,917 priority patent/US20040039166A1/en
Publication of WO2002012274A2 publication Critical patent/WO2002012274A2/en
Publication of WO2002012274A3 publication Critical patent/WO2002012274A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

IAPL-3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IAPL-3 polypeptides and polynucleotides in diagnostic assays.
PCT/EP2001/008934 2000-08-10 2001-08-02 Iapl-3 a protein inhibitor of apoptosis proteins Ceased WO2002012274A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2002518246A JP2004505639A (en) 2000-08-10 2001-08-02 IAPL-3, a protein inhibitor of apoptotic proteins
CA002418834A CA2418834A1 (en) 2000-08-10 2001-08-02 Iapl-3 a protein inhibitor of apoptosis proteins
EP01971851A EP1307483A2 (en) 2000-08-10 2001-08-02 Iapl-3 a protein inhibitor of apoptosis proteins
AU2001291722A AU2001291722A1 (en) 2000-08-10 2001-08-02 IAPL-3 A novel protein inhibitor of apoptosis proteins
US10/343,917 US20040039166A1 (en) 2000-08-10 2001-08-02 Iapl-3 a novel protein inhibitor of apoptosis protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00117145 2000-08-10
EP00117145.3 2000-08-10

Publications (2)

Publication Number Publication Date
WO2002012274A2 WO2002012274A2 (en) 2002-02-14
WO2002012274A3 true WO2002012274A3 (en) 2002-07-04

Family

ID=8169487

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/008934 Ceased WO2002012274A2 (en) 2000-08-10 2001-08-02 Iapl-3 a protein inhibitor of apoptosis proteins

Country Status (6)

Country Link
US (1) US20040039166A1 (en)
EP (1) EP1307483A2 (en)
JP (1) JP2004505639A (en)
AU (1) AU2001291722A1 (en)
CA (1) CA2418834A1 (en)
WO (1) WO2002012274A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062943A2 (en) * 1998-06-02 1999-12-09 Millenium Pharmaceuticals, Inc. Novel molecules of the aip-related protein family and uses thereof
WO2001066722A1 (en) * 2000-03-08 2001-09-13 Human Genome Sciences, Inc. Immune system-related polynucleotides, polypeptides, and antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062943A2 (en) * 1998-06-02 1999-12-09 Millenium Pharmaceuticals, Inc. Novel molecules of the aip-related protein family and uses thereof
WO2001066722A1 (en) * 2000-03-08 2001-09-13 Human Genome Sciences, Inc. Immune system-related polynucleotides, polypeptides, and antibodies

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 11 November 1999 (1999-11-11), HILLIER L. ET AL.: "au70h07.x1 Schneider fetal brain 00004 Homo sapiens cDNA clone", XP002194875 *
DATABASE EMBL 23 August 1999 (1999-08-23), BIRREN B. ET AL.: "Homo sapiens chromosome, clone RP11-44F24", XP002194874 *
DATABASE EMBL 3 July 2000 (2000-07-03), DIAS NETO E. ET AL.: ""RC0-HT0613-210300-032-h12 HT0613 Homo sapiens cDNA, mRNA sequence" *
DIAS NETO EMMANUEL ET AL: "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 97, no. 7, 28 March 2000 (2000-03-28), March 28, 2000, pages 3491 - 3496, XP002194873, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP1307483A2 (en) 2003-05-07
JP2004505639A (en) 2004-02-26
US20040039166A1 (en) 2004-02-26
WO2002012274A2 (en) 2002-02-14
CA2418834A1 (en) 2002-02-14
AU2001291722A1 (en) 2002-02-18

Similar Documents

Publication Publication Date Title
HK1053840A1 (en) Novel compounds
WO2001066690A3 (en) Novel compounds
WO2001072961A3 (en) Novel compounds
WO2001004141A3 (en) Seripancrin
WO2001083744A3 (en) Natrium-calcium exchanger protein
EP0885959A3 (en) Human Wnt-5b protein
EP0943684A3 (en) Frizzled-like polypeptides and polynucleotides
WO2002008253A3 (en) A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
WO2002020562A3 (en) Family member of inhibitor of apoptosis proteins
EP0890646A3 (en) HE2NW40 Serine Protease
WO2001079269A3 (en) Lipid binding protein 4
WO2001068816A8 (en) Human histamine h3 gene variant-3
WO2001083771A3 (en) Human phospholipase c delta 5
WO2001077147A3 (en) New bromodomain protein
WO2002008252A3 (en) Novel protein containing ring finger domaine r1p4
WO2001085937A3 (en) Regulator of g protein signalling (rgs8)
WO2001055428A3 (en) Mprot45 metalloprotease
WO2001077321A3 (en) Identification of a human gaba transporter
WO2002016415A3 (en) Identification of a cam-kinase ii inhibitor
WO1999038885A3 (en) Sbsemvl polypeptides, being members of the semaphorin protein family, and polynucleotides encoding the same
WO2002014355A3 (en) Novel mitogen activated kinase
AU2002311620A1 (en) Methods of making and using expression constructs for the expression of recombinant proteins
WO2001077148A3 (en) Human lipid binding protein 1
WO2001062779A3 (en) New transcription factor carp-2
WO2001068703A8 (en) Human histamine h3 gene variant-2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001971851

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001291722

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002518246

Country of ref document: JP

Ref document number: 2418834

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2001971851

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10343917

Country of ref document: US

WWR Wipo information: refused in national office

Ref document number: 2001971851

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001971851

Country of ref document: EP